| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.05 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |